Inventor · disambiguated record
John A. Josey
Also filed as: JOSEY JOHN · JOSEY JOHN A · JOSEY JOHN ANTHONY
25 granted patents·11 pending applications·375 citations·filing 1998–2022
96Inventor score
Files withPELOTON THERAPEUTICS INC16AMGEN INC9BLATT LAWRENCE M4ARRAY BIOPHARMA INC2ANDREWS STEVEN W1
Top patents by PatentIndex Score
36 records- 0197US6022884ASubstituted pyridine compounds and methods of useAMGEN INC·Filed 1998·Granted Feb 8, 2000·207 cites·18 claims
- 0293USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0393US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0493US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0593US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0693US6458813B1Substituted pyridine compounds and methods of useAMGEN INC·Filed 2001·Granted Oct 1, 2002·45 cites·17 claims
- 0792US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 0890US6333341B1Substituted pyridine compounds and methods of useAMGEN INC·Filed 2000·Granted Dec 25, 2001·31 cites·11 claims
- 0989US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1087US10335388B2Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·4 cites·21 claims
- 1187US10278942B2Compositions for use in treating pulmonary arterial hypertensionPELOTON THERAPEUTICS INC·Filed 2016·Granted May 7, 2019·7 cites·16 claims
- 1286US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1381US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 1481US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 1576US6291450B1Carboxylic acid substituted heterocycles, derivatives thereof and methods of useAMGEN INC·Filed 2000·Granted Sep 18, 2001·6 cites·12 claims
- 1675US10512626B2Compositions for use in treating glioblastomaPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 24, 2019·1 cites·17 claims
- 1772US10786480B2Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereofPELOTON THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·1 cites·29 claims
- 1872US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1968US2009111982A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2067US2009286843A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2165US2009105471A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2265US2009111969A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 2361US7022690B2Carboxylic acid substituted heterocycles, derivatives thereof and methods of useAMGEN INC·Filed 2004·Granted Apr 4, 2006·0 cites·12 claims
- 2460US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2558US6184237B1Substituted pyridine compounds and methods of useAMGEN INC·Filed 1999·Granted Feb 6, 2001·10 cites·20 claims
- 2656US6838454B2Carboxylic acid substituted heterocycles, derivatives thereof and methods of useAMGEN INC·Filed 2003·Granted Jan 4, 2005·0 cites·13 claims
- 2756US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 2855US2005130954A1AKT protein kinase inhibitorsFiled 2004·Application pending·0 cites
- 2953US2007142413A1Pyrazole derivatives as inhibitors of receptor tyrosone kinasesBLOCK MICHAEL H·Filed 2004·Application pending·0 cites
- 3052US6593351B2Carboxylic acid substituted heterocycles, derivatives thereof and methods of useAMGEN INC·Filed 2001·Granted Jul 15, 2003·0 cites·12 claims
- 3148US6911554B2Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactionsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 28, 2005·0 cites·6 claims
- 3246US2021015764A1Methods of reducing inflammation of the digestive system with inhibitors of hif-2- alphaPELOTON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3342US2010152219A1Pyrazole derivatives as inhibitors of receptor tyrosine kinasesASTRAZENECA R & D·Filed 2010·Application pending·0 cites
- 3437US6335329B1Carboxylic acid substituted heterocycles, derivatives thereof and methods of useAMGEN INC·Filed 1998·Granted Jan 1, 2002·1 cites·24 claims
- 3536US8865726B2Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsANDREWS STEVEN W·Filed 2010·Granted Oct 21, 2014·0 cites·45 claims
- 3635US10040767B2Benzimidazole derivatives and uses thereofPELOTON THERAPEUTICS INC·Filed 2015·Granted Aug 7, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when John A. Josey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →